BAILARD, INC. Q2 2018 Filing

Filed August 8, 2018

Portfolio Value

$1.7T

Holdings

504

Report Date

Q2 2018

Filing Type

13F-HR

All Holdings (504 positions)

#StockSharesValue% PortfolioType
501
TRNSTRANSCAT INC
10,356$196.0M0.01%
502
—EPIZYME INC
12,000$163.0M0.01%
503
MUFGMITSUBISHI UFJ FINL GROUP IN
25,971$147.0M0.01%
504
—NAVIDEA BIOPHARMACEUTICALS I
10,000$2.0M0.00%
PreviousPage 6 of 6